Literature DB >> 19179016

High-grade urothelial carcinoma of the urinary bladder showing acquisition of microcystic histology in the penile metastasis: histogenetic considerations.

Valeria Barresi1, Antonio Ieni, Carlo Magno, Gaetano Barresi.   

Abstract

Microcystic urothelial carcinoma is a rare variant of transitional cell carcinoma with an indefinite prognostic significance. Herein, we report for the first time the acquisition of microcystic histology in the penile metastasis of a high-grade urothelial carcinoma of the urinary bladder. The patient died of disseminated disease six months later. The immunohistochemical evaluation of mucin expression in the primitive and metastatic tumor suggests that the microcystic histotype may descend from the primitive urothelial carcinoma through a process of dedifferentiation and subsequent redifferentiation. In conclusion, the acquisition of microcystic histology seems to be associated with an aggressive clinical course of the urothelial carcinoma, as already suggested by other authors. Future studies investigating mucin expression in microcystic urothelial carcinoma may help to define the histogenesis of this tumor.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19179016     DOI: 10.1016/j.prp.2008.12.005

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  4 in total

1.  Malignant priapism secondary to metastatic prostate cancer: a case report and review of literature.

Authors:  Yu-Hsiang Lin; Jerry J Kim; Ned B Stein; Mohit Khera
Journal:  Rev Urol       Date:  2011

2.  Microcystic urothelial carcinoma: a case report.

Authors:  Mengyao Liu; Shuaichen Liu; Lei Bao; Weiyi Chen; Ping Yang; Huihui Zhou
Journal:  Int J Clin Exp Pathol       Date:  2020-11-01

Review 3.  Microcystic variant of urothelial carcinoma.

Authors:  Anthony Kodzo-Grey Venyo
Journal:  Adv Urol       Date:  2013-12-02

Review 4.  Prognosis of men with penile metastasis and malignant priapism: a systematic review.

Authors:  Andrea Cocci; Oliver W Hakenberg; Tommaso Cai; Gabriella Nesi; Lorenzo Livi; Beatrice Detti; Andrea Minervini; Girolamo Morelli; Marco Carini; Sergio Serni; Mauro Gacci
Journal:  Oncotarget       Date:  2017-12-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.